#151290

Anti-ICAM1 [P1W16]

Cat. #151290

Anti-ICAM1 [P1W16]

Cat. #: 151290

Unit size: 100 ug

Availability: 3-4 weeks

Target: ICAM1 (CD54)

Class: Monoclonal

Application: FACS ; IHC ; IF ; IP

Reactivity: Human

Host: Mouse

£300.00

This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.

Contributor

Inventor: Deborah Buckle ; John Marshall

Institute: Queen Mary University of London

Tool Details
Target Details
Applications
Handling

Tool Details

*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)

  • Name: Anti-ICAM1 [P1W16]
  • Alternate name: Intercellular Adhesion Molecule 1; Major Group Rhinovirus Receptor; ICAM-1; Cell Surface Glycoprotein P3.58; Human Rhinovirus Receptor; P3.58; CD54; BB2
  • Research fields: Cell biology;Immunology;Stem cell biology;Tissue-specific biology
  • Clone: P1W16
  • Class: Monoclonal
  • Conjugation: Unconjugated
  • Molecular weight: 85-115
  • Strain: Balb/c
  • Reactivity: Human
  • Host: Mouse
  • Application: FACS ; IHC ; IF ; IP
  • Description: ICAMs are members of the immunoglobulin superfamily that is characterised by the presence of immunoglobulin-like domains. ICAM-1 is expressed in haemopoietic cells and vascular endothelium. Cytokine activation causes ICAM-1 expression in other cell types such as fibroblasts and keratinocytes. ICAM-1 is involved in leukocyte recruitment and inflammation. ICAM-1 binds LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18). P1W16 may be useful for prognosis of malignant melanoma.
  • Immunogen: V(+)B2- Human Ocular melanoma line
  • Isotype: IgG1 kappa
  • Recommended controls: A375M melanoma or tonsil

Target Details

  • Target: ICAM1 (CD54)
  • Molecular weight: 85-115
  • Target background: ICAMs are members of the immunoglobulin superfamily that is characterised by the presence of immunoglobulin-like domains. ICAM-1 is expressed in haemopoietic cells and vascular endothelium. Cytokine activation causes ICAM-1 expression in other cell types such as fibroblasts and keratinocytes. ICAM-1 is involved in leukocyte recruitment and inflammation. ICAM-1 binds LFA-1 (CD11a/CD18) and Mac-1 (CD11b/CD18). P1W16 may be useful for prognosis of malignant melanoma.

Applications

  • Application: FACS ; IHC ; IF ; IP

Handling

  • Format: Liquid
  • Concentration: 0.9mg/ml
  • Unit size: 100 ug
  • Storage buffer: DMEM + 5% FCS
  • Storage conditions: -15° C to -25° C
  • Shipping conditions: Shipping at 4° C